A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
Clinical trial NCT04762511 · TERMINATED
Trial details
- NCT number
- NCT04762511
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-02
- Primary completion
- 2021-05-26
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.